Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 25
Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 26
Aug 31, 2023, 19:04
Naveen Pemmaraju: Ph2 CLIA with or without sorafenib for upfront AML therapy.
Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center, recently tweeted:
“Brand new paper alert from our group Ph2 CLIA with or without sorafenib for upfront AML therapy led by Tapan Kadia, Hagop Kantarjian, Gautam Borthakur, Naval Daver, Naveen Pemmaraju, Nitin Jain and Musa Yilmaz.”
For the article click here.
Source: Naveen Pemmaraju/Twitter
Jul 26, 2024, 08:02